In May, 2018, Chinese government published the first rare disease national list, the list contains 121 diseases which published by China National Health Commission in together with other four Chinese government agencies. Although there is not yet a definition of rare disease in China, this first list contains Albinism, Hemophilia, Neonatal Diabetes Mellitus are all…
The second batch of off patent drugs published by China Center for Drug Evaluation (CDE) contains 7 abroad approved drugs, which are regarded as clinically valued and the patent of chemical compounds has been expired, invalid or terminated in China, however, there is still no generic drug application in China until October, 2018. The Anti-HIV…
On Mar 28th, 2019, China CDE announced a new batch of Reference Listed Drugs on its website for public opinion from Mar 28th to April 15th. It’s the 21st batch of RLD list published officially since China initiated the industry-wide generic drug consistency evaluation, and it’s the first time injection RLD being included. Among the…
